Search results
Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?
Zacks via Yahoo Singapore Finance· 1 week agoIonis Pharmaceuticals (IONS) witnessed a jump in share price last session on above-average trading...
Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Zacks via Yahoo Singapore Finance· 2 weeks agoIonis (IONS) out-licenses the rights for its HAE drug to Otsuka in the Asia-Pacific region. The...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 2 months agoIonis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript May 7, 2024 Ionis...
Vanguard Health Care Fund's Strategic Moves: Spotlight on Ono Pharmaceutical Co Ltd
GuruFocus.com via Yahoo Singapore Finance· 7 months agoInsight into the Fund's Latest Investment Decisions and Portfolio Adjustments Vanguard Health Care...
Ionis Pharmaceuticals Inc (IONS) Surpasses Revenue Guidance for 2023, Sets Sights on 2024 Growth
GuruFocus.com via Yahoo Singapore Finance· 4 months agoTotal Revenue: Increased to $788 million in 2023 from $587 million in 2022. Operating Expenses: Rose...
YouTube Works Awards Celebrate Creativity, Innovation and Inclusivity
MediaOutReach via Yahoo Singapore Finance· 2 years agoHSBC, Café de Coral and Otsuka Pharmaceutical (H.K.) Ltd. recognised for producing Hong Kong’s most...
Is it a Good Time to Invest in Aurinia Pharmaceuticals (AUPH)?
Zacks via Yahoo Singapore Finance· 9 months agoCanada-based Aurinia Pharmaceuticals AUPH makes medicines to treat autoimmune, kidney and rare...
Aurinia's (AUPH) Oral Lupus Drug Lupkynis Gets European Approval
Zacks via Yahoo Singapore Finance· 2 years agoAurinia Pharmaceutical (AUPH) receives marketing authorization from the European Union for its...
Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
Zacks via Yahoo Singapore Finance· 2 months agoEsperion Therapeutics, Inc. ESPR reported earnings of 34 cents per share in the first quarter of...
Esperion (ESPR) Q4 Loss Narrows, Revenues Miss, Stock Down
Zacks via Yahoo Singapore Finance· 1 year agoEsperion Therapeutics ESPR incurred a loss per share of 76 cents per share in the fourth quarter of...